Carasent ASA (CARA) - Total Assets
Based on the latest financial reports, Carasent ASA (CARA) holds total assets worth Skr921.88 Million SEK (≈ $99.21 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check how aggressively does Carasent ASA reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Carasent ASA - Total Assets Trend (2002–2025)
This chart illustrates how Carasent ASA's total assets have evolved over time, based on quarterly financial data. Check Carasent ASA cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Carasent ASA - Asset Composition Analysis
Current Asset Composition (December 2025)
Carasent ASA's total assets of Skr921.88 Million consist of 23.1% current assets and 76.9% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 14.8% |
| Accounts Receivable | Skr63.66 Million | 6.8% |
| Inventory | Skr0.00 | 0.0% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr204.02 Million | 21.7% |
| Goodwill | Skr486.85 Million | 51.7% |
Asset Composition Trend (2002–2025)
This chart illustrates how Carasent ASA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see CARA market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Carasent ASA's current assets represent 23.1% of total assets in 2025, a decrease from 71.5% in 2002.
- Cash Position: Cash and equivalents constituted 14.8% of total assets in 2025, down from 62.4% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 72.0% of total assets, an increase from 10.0% in 2002.
- Asset Diversification: The largest asset category is goodwill at 51.7% of total assets.
Carasent ASA Competitors by Total Assets
Key competitors of Carasent ASA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
INVENTURUS KNOWLEDGE SO L
NSE:IKS
|
India | Rs36.06 Billion |
|
Waystar Holding Corp. Common Stock
NASDAQ:WAY
|
USA | $5.84 Billion |
|
DocCheck AG
XETRA:AJ91
|
Germany | €55.68 Million |
|
Kovo Healthtech Corp
V:KOVO
|
Canada | CA$6.64 Million |
|
Pro Medicus Ltd
AU:PME
|
Australia | AU$533.91 Million |
|
Echoiq Ltd
AU:EIQ
|
Australia | AU$17.99 Million |
|
ARTRYA Ltd
AU:AYA
|
Australia | AU$92.19 Million |
|
Cogstate Ltd
AU:CGS
|
Australia | AU$64.77 Million |
Carasent ASA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.58 | 2.74 | 6.05 |
| Quick Ratio | 1.58 | 2.74 | 6.51 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr71.60 Million | Skr197.95 Million | Skr197.92 Million |
Carasent ASA - Advanced Valuation Insights
This section examines the relationship between Carasent ASA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.10 |
| Latest Market Cap to Assets Ratio | 0.18 |
| Asset Growth Rate (YoY) | -12.2% |
| Total Assets | Skr941.01 Million |
| Market Capitalization | $165.12 Million USD |
Valuation Analysis
Below Book Valuation: The market values Carasent ASA's assets below their book value (0.18x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Carasent ASA's assets decreased by 12.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Carasent ASA (2002–2025)
The table below shows the annual total assets of Carasent ASA from 2002 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr941.01 Million ≈ $101.27 Million |
-12.24% |
| 2024-12-31 | Skr1.07 Billion ≈ $115.40 Million |
-1.95% |
| 2023-12-31 | Skr1.09 Billion ≈ $117.69 Million |
-20.22% |
| 2022-12-31 | Skr1.37 Billion ≈ $147.53 Million |
+5.39% |
| 2021-12-31 | Skr1.30 Billion ≈ $139.99 Million |
+157.61% |
| 2020-12-31 | Skr504.95 Million ≈ $54.34 Million |
+269.49% |
| 2019-12-31 | Skr136.66 Million ≈ $14.71 Million |
+14.61% |
| 2018-12-31 | Skr119.24 Million ≈ $12.83 Million |
+93.03% |
| 2017-12-31 | Skr61.78 Million ≈ $6.65 Million |
+22.89% |
| 2016-12-31 | Skr50.27 Million ≈ $5.41 Million |
-76.90% |
| 2015-12-31 | Skr217.57 Million ≈ $23.41 Million |
-4.66% |
| 2014-12-31 | Skr228.20 Million ≈ $24.56 Million |
+1.73% |
| 2013-12-31 | Skr224.32 Million ≈ $24.14 Million |
+5.52% |
| 2012-12-31 | Skr212.59 Million ≈ $22.88 Million |
+6.21% |
| 2011-12-31 | Skr200.16 Million ≈ $21.54 Million |
+1.96% |
| 2010-12-31 | Skr196.31 Million ≈ $21.13 Million |
+1.07% |
| 2009-12-31 | Skr194.24 Million ≈ $20.90 Million |
-20.75% |
| 2008-12-31 | Skr245.09 Million ≈ $26.38 Million |
+10.65% |
| 2007-12-31 | Skr221.49 Million ≈ $23.84 Million |
-19.69% |
| 2006-12-31 | Skr275.78 Million ≈ $29.68 Million |
+95.21% |
| 2005-12-31 | Skr141.27 Million ≈ $15.20 Million |
+117.52% |
| 2004-12-31 | Skr64.95 Million ≈ $6.99 Million |
+32.88% |
| 2003-12-31 | Skr48.88 Million ≈ $5.26 Million |
-19.43% |
| 2002-12-31 | Skr60.66 Million ≈ $6.53 Million |
-- |
About Carasent ASA
Carasent AB (publ) provides cloud based electronic health record (EHR) systems solutions and platform services for healthcare sector in Nordics and Germany. The company offers Webdoc, Webcur, Metodika, Ad Curis, Ad Opus, and Data-AL solutions. It also provides Medrave, Vårdrummet, Ad Voca, and HPI Plustoo services, as well as an ecosystem of platform services, including solutions for patient comm… Read more